Related Experiment Video
Updated: May 24, 2026
Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
The genomic and proteomic blueprint of mouse megakaryocytes derived from embryonic stem cells
V Merico1, M Zuccotti, D Carpi
1Laboratorio di Biologia dello Sviluppo, Dipartimento di Biologia e Biotecnologie Lazzaro Spallanzani, University of Pavia, Pavia, Italy.
Background:
Platelets are specialized cells, produced by megakaryocytes (MKs) in the bone marrow, which represent the first defense against hemorrhage. There are many diseases where platelet production or function is impaired, with severe consequences for patients. Therefore, new insights into the process of MK differentiation and platelet formation would have a major impact on both basic and clinical research.
Objectives:
Embryonic stem (ES) cells represent a good in vitro model to study the differentiation of MKs, with the possibility of being genetically engineered and constituting an unlimited source of MKs. However, lack of knowledge about the molecular identity of ES-derived MKs (ES-MKs) may prevent any further development and application of this model.
Methods:
This paper presents the first comprehensive transcriptional and proteome profile analyses of mouse ES-MKs in comparison with MKs derived from mouse fetal liver progenitors (FL-MKs).
Results:
In ES-MKs we found a down-regulation of cytoskeleton proteins, specific transcription factors and membrane receptors at both transcriptional and protein levels. At the phenotypic level, this molecular blueprint was displayed by ES-MKs' lower polyploidy, lower nuclear/cytoplasm ratio and reduced capacity to form proplatelets and releasing platelets.
Conclusions:
Overall our data demonstrate that ES-MKs represent a useful model to clarify many aspects of both MK physiology and pathological conditions where impaired MK functions are related to defective MK development, as in inherited thrombocytopenias and primary myelofibrosis.
Insights
Embryonic stem cell-derived megakaryocytes (ES-MKs) show molecular differences impacting platelet formation. This study provides a comprehensive profile of ES-MKs, aiding research into platelet disorders.
Area of Science:
- Hematology
- Stem Cell Biology
- Molecular Biology
Background:
- Platelets are crucial for hemostasis, and their impaired production or function leads to severe diseases.
- Understanding megakaryocyte (MK) differentiation and platelet formation is vital for basic and clinical research.
Purpose of the Study:
- To characterize the molecular identity of mouse embryonic stem (ES) cell-derived MKs (ES-MKs).
- To compare ES-MKs with MKs derived from fetal liver progenitors (FL-MKs) to understand their differentiation potential.
Main Methods:
- Comprehensive transcriptional and proteome profiling of mouse ES-MKs and FL-MKs.
- Phenotypic analysis including polyploidy, nuclear/cytoplasm ratio, and proplatelet formation capacity.
Main Results:
- ES-MKs exhibit down-regulation of cytoskeleton proteins, transcription factors, and membrane receptors at both transcript and protein levels.
- Phenotypically, ES-MKs show lower polyploidy, reduced nuclear/cytoplasm ratio, and impaired proplatelet formation and platelet release.
Conclusions:
- ES-MKs serve as a valuable model for studying MK physiology and diseases linked to defective MK development, such as inherited thrombocytopenias and primary myelofibrosis.
- The molecular and phenotypic differences identified highlight specific aspects of MK development and platelet production.
